← Open Payments lookup

BRIAN SO: Open Payments

NPI 1841499100 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,131 in 130 payments from 15 companies in 2025. Trend: 2023 $9,997 · 2024 $2,409 · 2025 $2,131

Food & beverage: $2,131
CompanyPaymentsAmount
ABBVIE INC.43$552
Takeda Pharmaceuticals U.S.A., Inc.18$318
Janssen Biotech, Inc.10$207
Ardelyx, Inc.11$207
PFIZER INC.15$188
Phathom Pharmaceuticals, Inc.7$128
Madrigal Pharmaceuticals5$116
GENZYME CORPORATION5$112
Lilly USA, LLC5$99
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$82

Products named: ENTYVIO, TREMFYA, IBSRELA, SKYRIZI, RINVOQ, VOQUEZNA, REZDIFFRA, XELJANZ.

Industry payments across TX — which companies pay providers there.